BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Garbuzenko DV. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis. World J Gastroenterol 2015; 21(20): 6117-6126 [PMID: 26034348 DOI: 10.3748/wjg.v21.i20.6117]
URL: https://www.wjgnet.com/1007-9327/full/v21/i20/6117.htm
Number Citing Articles
1
Shirui Qi, Zhongyin Wu, Heyue Jia, Bo Jin, Hui Li, Chuntao Liu, Shangqing Chang, Haiyan Zhu, Yating Zhu, Zheng Lu, Peng Li, Haibin Su, Jiang Xiong, Yu Wang, Wei Guo, Gang Sun. Sudden Death2021; : 369 doi: 10.1007/978-981-15-7002-5_23
2
Cyriac Abby Philips, Aprajita Awasthi, Philip Augustine, Varghese Thomas. Variceal Bleeding in Liver Cirrhosis2021; : 13 doi: 10.1007/978-981-15-7249-4_2
3
Andressa de Souza BERTOLDI, Camila Roginski GUETTER, Gabriel Antonio COLTRO, Larissa Maria VOSGERAU, Laura Maria Viscardi BRIGHENTI, Natália Izycki FAUAT, Fernando Bermudez KUBRUSLY, Camila Aparecida Moraes MARQUES, Luiz Fernando KUBRUSLY. CARVEDILOL AS PRIMARY PROPHYLAXIS FOR GASTRIC VARICEAL BLEEDING IN PORTAL HYPERTENSION MODEL IN RATSABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2020; 33(3) doi: 10.1590/0102-672020200003e1525
4
Ashish Kumar, Noor Muhammad Khan, Shrihari Anil Anikhindi, Praveen Sharma, Naresh Bansal, Vikas Singla, Anil Arora. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from IndiaWorld Journal of Gastroenterology 2017; 23(4): 687-696 doi: 10.3748/wjg.v23.i4.687
5
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev. Hepatic hydrothorax: An update and review of the literatureWorld Journal of Hepatology 2017; 9(31): 1197-1204 doi: 10.4254/wjh.v9.i31.1197
6
Huan-Wen Chiu, Kuo-Feng Hua, Jordi Gracia-Sancho. Hepatoprotective Effect of Wheat-Based Solid-State Fermented Antrodia cinnamomea in Carbon Tetrachloride-Induced Liver Injury in RatPLOS ONE 2016; 11(4): e0153087 doi: 10.1371/journal.pone.0153087
7
Harikumar Nair, Annalisa Berzigotti, Jaime Bosch. Emerging therapies for portal hypertension in cirrhosisExpert Opinion on Emerging Drugs 2016; 21(2): 167 doi: 10.1080/14728214.2016.1184647
8
Eula Plana Tetangco, Rogelio G. Silva, Edgar V. Lerma. Portal hypertension: Etiology, evaluation, and managementDisease-a-Month 2016; 62(12): 411 doi: 10.1016/j.disamonth.2016.08.001
9
Zhenyu Li, Xi Wang, Jinwei Chen, Zusheng Zang, Feng Zhou, Liqin Shi, Li Li, Chengwei Chen, Xiaojin Wang, Yinpeng Jin, Qingchun Fu. Efficacy Analysis of Gastric Coronary Venous TH Glue Embolization with Splenectomy for Treating Cirrhotic Portal HypertensionExploratory Research and Hypothesis in Medicine 2019; 0(000): 1 doi: 10.14218/ERHM.2019.00010
10
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev, Evgeniy Leonidovich Kazachkov. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectivesWorld Journal of Gastroenterology 2018; 24(33): 3738-3748 doi: 10.3748/wjg.v24.i33.3738
11
Georgios N Kalambokis, Gerasimos Baltayiannis, Dimitrios Christodoulou. von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosisWorld Journal of Gastroenterology 2016; 22(19): 4786-4788 doi: 10.3748/wjg.v22.i19.4786
12
Damien Leith, Rajeshwar P. Mookerjee. Evidence-based Gastroenterology and Hepatology 4e2019; : 619 doi: 10.1002/9781119211419.ch41
13
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev. Current approaches to the management of patients with cirrhotic ascitesWorld Journal of Gastroenterology 2019; 25(28): 3738-3752 doi: 10.3748/wjg.v25.i28.3738
14
Wolfgang Kreisel, Denise Schaffner, Adhara Lazaro, Jonel Trebicka, Irmgard Merfort, Annette Schmitt-Graeff, Peter Deibert. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal HypertensionInternational Journal of Molecular Sciences 2020; 21(17): 6223 doi: 10.3390/ijms21176223
15
Dmitry V. Garbuzenko. Principles of primary prophylaxis of bleeding from oesophagealvaricies in patients with liver cirrhosisClinical Medicine (Russian Journal) 2016; 94(7): 503 doi: 10.18821/0023-2149-2016-94-7-503-509
16
Dmitry Victorovich Garbuzenko. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleedingCurrent Medical Research and Opinion 2016; 32(3): 467 doi: 10.1185/03007995.2015.1124846
17
Yan Zhang, Da-Feng Mao, Mei-Wu Zhang, Xiao-Xiang Fan. Clinical value of liver and spleen shear wave velocity in predicting the prognosis of patients with portal hypertensionWorld Journal of Gastroenterology 2017; 23(45): 8044-8052 doi: 10.3748/wjg.v23.i45.8044
18
Francielli Licks, Renata Minuzzo Hartmann, Elizângela Schemitt, Josieli Raskopf Colares, Lúcio Sarubbi Fillmann, Henrique Fillmann, Norma Possa Marroni. Inflammatory bowel and oxidative stress changes in an experimental model of portal hypertension: action of N-acetylcysteineJournal of Coloproctology 2016; 36(04): 231 doi: 10.1016/j.jcol.2016.05.005
19
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literatureJournal of Evidence-Based Medicine 2020; 13(4): 313 doi: 10.1111/jebm.12407